Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carmustine (BCNU) plus Teniposide (VM26) in Recurrent Malignant Glioma

Published:2014 Issue:5-6 Volume:86 Page:369-372
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Mack Frederic,Schäfer Niklas,Kebir Sied,Stuplich Moritz,Schaub Christina,Niessen Michael,Scheffler Björn,Herrlinger Ulrich,Glas Martin

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment;Biomedicine & Pharmacotherapy;2024-02

2. Safety and feasibility of intra-arterial delivery of teniposide to high grade gliomas after blood–brain barrier disruption: a case series;Journal of NeuroInterventional Surgery;2023-12-07

3. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery;Frontiers in Bioscience-Landmark;2023-10-12

4. Organocatalytic enantioselective construction of bicyclic γ-butrolactones;Chinese Chemical Letters;2023-07

5. Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults;Journal of Neuro-Oncology;2022-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP